Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Given Imaging Targeting M2A Reimbursement Beyond Obscure Bleeding

This article was originally published in The Gray Sheet

Executive Summary

A BlueCross BlueShield TEC assessment supporting capsule endoscopy for Crohn's disease diagnosis furthers Given Imaging's efforts to obtain coverage for indications beyond obscure bleeding

You may also be interested in...



Given’s PillCam Gets Positive Review For More Indications

An updated review of wireless endoscopic capsule technology supports additional indications for Given Imaging's ingestible PillCam while raising some safety concerns

Given’s PillCam Gets Positive Review For More Indications

An updated review of wireless endoscopic capsule technology supports additional indications for Given Imaging's ingestible PillCam while raising some safety concerns

PillCam ESO on the road to reimbursement

Given Imaging's miniature camera pill for detecting esophageal disorders should be described by CPT code 91110 along with a modifier 52, according to CMS. The decision will allow hospitals to uniformly report the procedure, with payment to be decided on a case-by-case basis until a coverage policy is determined. With coding in place, Given will be able to focus on securing coverage. The firm's first product - PillCam SB for small bowel disorder detection - is reimbursed under CPT code 91110 (1"The Gray Sheet" Nov. 17, 2003, p. 7)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019327

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel